We also DO have some non-vaccine drug therapies that work ( a lot better than hydroxychloroquine and ivermectin, according to random blind clinical trials). Those are Remdesivir, Molnupiravir, and Paxlovid. The US government has actually supported the development and testing by buying or committing to buy millions of doses. Remdesivir works by jamming RNA replication. Molnupiravir works by making RNA replicating so full of errors the replicated strand can never work. Paxlovid works by binding to the viral protease, preventing it from cutting up a multi-protein amino acid strand into functional proteins the virus needs for replication.

I listed them in order of increasing effectiveness, but they only work when given early while viral replication can be blocked. Ideally, that would be right after exposure. Remdesivir has an EUA. I think Molnupiravir has been approved by the FDA, but doesn't have an EUA yet. Paxlovid is in the approval process.

We also have a whole bunch of Monoclonal Antibodies that have EUAs. They also need to be given very early to be effective, and have the disadvantage of being evaded by new variants. The problem is that these are short or very short term solutions. MABs work for about 3 months (assuming you don't catch another variant that they don't protect against), and the drugs just work for the time you take them. So vaccination is way more effective.

Educating anyone benefits everyone.